Kaprio, T., Rasila, T., Hagström, J., Mustonen, H., Lankila, P., Haglund, C., & Andersson, L. C. (2019). Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer. PLoS One.

Kaprio, Tuomas, Tiina Rasila, Jaana Hagström, Harri Mustonen, Petri Lankila, Caj Haglund, a Leif C. Andersson. "Ornithine Decarboxylase Antizyme Inhibitor 2 (AZIN2) Is a Signature of Secretory Phenotype and Independent Predictor of Adverse Prognosis in Colorectal Cancer." PLoS One 2019.

Kaprio, Tuomas, et al. "Ornithine Decarboxylase Antizyme Inhibitor 2 (AZIN2) Is a Signature of Secretory Phenotype and Independent Predictor of Adverse Prognosis in Colorectal Cancer." PLoS One 2019.